Login: Password:  Do not remember me




E-BooksEvidence-biased Antidepressant Prescription Overmedicalisation, Flawed Research, and Conflicts of Interest



Evidence-biased Antidepressant Prescription Overmedicalisation, Flawed Research, and Conflicts of Interest
Evidence-biased Antidepressant Prescription: Overmedicalisation, Flawed Research, and Conflicts of Interest by Michael P. Hengartner
English | EPUB | 2022 | 355 Pages | ISBN : 3030825868 | 0.5 MB


This book addresses the over-prescribing of antidepressants in people with mostly mild and subthreshold depression. It outlines the steep increase in antidepressant prescription and critically examines the current scientific evidence on the efficacy and safety of antidepressants in depression. The book is not only concerned with the conflicting views as to whether antidepressants are useful or ineffective in various forms of depression, but also aims at detailing how flaws in the conduct and reporting of antidepressant trials have led to an overestimation of benefits and underestimation of harms.
This book addresses the over-prescribing of antidepressants in people with mostly mild and subthreshold depression. It outlines the steep increase in antidepressant prescription and critically examines the current scientific evidence on the efficacy and safety of antidepressants in depression. The book is not only concerned with the conflicting views as to whether antidepressants are useful or ineffective in various forms of depression, but also aims at detailing how flaws in the conduct and reporting of antidepressant trials have led to an overestimation of benefits and underestimation of harms.
The transformation of the diagnostic concept of depression from a rare but serious disorder to an over-inclusive, highly prevalent but predominantly mild and self-limiting disorder is central to the books argument. It maintains that biological reductionism in psychiatry and pharmaceutical marketing reframed depression as a brain disorder, corroborating the overemphasis on drug treatment in both research and practice.
Finally, the author goes on to explore how pharmaceutical companies have distorted the scientific literature on the efficacy and safety of antidepressants and how patient advocacy groups, leading academics, and medical organisations with pervasive financial ties to the industry helped to promote systematically biased benefit-harm evaluations, affecting public attitudes towards antidepressants as well as medical education, training, and practice.




[b]Please Help Me Click Connect Icon Below Here and Share News to Social Network | Thanks you !


📌🔥Contract Support Link FileHost🔥📌
✅💰Contract Email: [email protected]

Help Us Grow – Share, Support

We need your support to keep providing high-quality content and services. Here’s how you can help:

  1. Share Our Website on Social Media! 📱
    Spread the word by sharing our website on your social media profiles. The more people who know about us, the better we can serve you with even more premium content!
  2. Get a Premium Filehost Account from Website! 🚀
    Tired of slow download speeds and waiting times? Upgrade to a Premium Filehost Account for faster downloads and priority access. Your purchase helps us maintain the site and continue providing excellent service.

Thank you for your continued support! Together, we can grow and improve the site for everyone. 🌐

[related-news]

Related News

    {related-news}
[/related-news]

Comments (0)

Ooops, Error!

Information

Users of Guests are not allowed to comment this publication.

Search



Updates




Partner


» TutBB
» Byte
» Crawli
» Warezomen
» Warez-DDL
» Raidrush
» KATZCD
» Free Ebooks Library

Your Link Here ?
(Pagerank 4 or above)